Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00882089 · ClinicalTrials.gov registry record · Phase 4
Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients
A Phase 4 study, sponsored by Cancer Center of Irvine.
- Completed
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT00882089: Completed Phase 4 study, sponsored by Cancer Center of Irvine.
NCT00882089 is a Phase 4 study that has completed, run by Cancer Center of Irvine. The registered enrollment target is 13 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00882089, a Phase 4 study, has completed, sponsored by Cancer Center of Irvine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a Contura catheter can avoid a radiation "hot spot" in the skin and improve tissue-balloon conformance in early-stage breast cancer patients undergoing accelerated partial breast irradiation.
Interventions
- DEVICE Contura catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
What the finished NCT00882089 record still lists
NCT00882089 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Contura catheter is the first listed.
NCT00882089 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00882089 about?
NCT00882089 is a clinical study titled "Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients". The purpose of this study is to determine if a Contura catheter can avoid a radiation "hot spot" in the skin and improve tissue-balloon conformance in early-stage breast cancer patients undergoing accelerated partial breast irradiation.
What is the current status of trial NCT00882089?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2007-10. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00882089?
The interventions under investigation include: Contura catheter (DEVICE).
Who is sponsoring clinical trial NCT00882089?
This trial is sponsored by Cancer Center of Irvine, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00882089's enrollment target sits among peer trials
13 1910th of 2000 higher than 88 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia